-transparent.png){kind=logo}
A 55-year-old man was treated during 22 months with chlorambucil (total dose : 4 218 g) for glomerulonephritis. Towards the end of the treatment, he developed acute myelomonocytic leukaemia and died of this complication. The authors underline the oncogenetic dangers of the association dysimmune disease/immunosuppressive treatment and draw attention to the almost regular preleukaemic phase with its well-known cytological, biochemical, immunological, cytogenetic and evolutive criteria.
Related Publications
A P Blanc, and
J A Gastaut, and
G Sébahoun, and
P Dalivoust, and
A Murisasco, and
Y Carcassonne
January 1975,
Sangre,
A P Blanc, and
J A Gastaut, and
G Sébahoun, and
P Dalivoust, and
A Murisasco, and
Y Carcassonne
February 1977,
Journal de radiologie, d'electrologie, et de medecine nucleaire,
A P Blanc, and
J A Gastaut, and
G Sébahoun, and
P Dalivoust, and
A Murisasco, and
Y Carcassonne
June 1993,
Archives of disease in childhood,
A P Blanc, and
J A Gastaut, and
G Sébahoun, and
P Dalivoust, and
A Murisasco, and
Y Carcassonne
January 1979,
Nouvelle revue francaise d'hematologie,
A P Blanc, and
J A Gastaut, and
G Sébahoun, and
P Dalivoust, and
A Murisasco, and
Y Carcassonne
January 1981,
Nouvelle revue francaise d'hematologie,
A P Blanc, and
J A Gastaut, and
G Sébahoun, and
P Dalivoust, and
A Murisasco, and
Y Carcassonne
January 1981,
Anesthesie, analgesie, reanimation,
A P Blanc, and
J A Gastaut, and
G Sébahoun, and
P Dalivoust, and
A Murisasco, and
Y Carcassonne
January 1978,
Materia medica Polona. Polish journal of medicine and pharmacy,
A P Blanc, and
J A Gastaut, and
G Sébahoun, and
P Dalivoust, and
A Murisasco, and
Y Carcassonne
February 1979,
La Nouvelle presse medicale,
A P Blanc, and
J A Gastaut, and
G Sébahoun, and
P Dalivoust, and
A Murisasco, and
Y Carcassonne
January 1980,
Sangre,
A P Blanc, and
J A Gastaut, and
G Sébahoun, and
P Dalivoust, and
A Murisasco, and
Y Carcassonne
January 1981,
Sangre,
